AI Strategic Intelligence Platforms: Speed and Depth Without Losing Human Oversight
Strategic intelligence platforms combine AI reasoning with financial and competitive frameworks to replace weeks of manual analysis. Percision stands apart by running company data through 83 structured reasoning steps across seven specialist models—CEO, CFO, COO, CTO, CMO, VP Business Development, and VP Sales—to generate institutional-grade output in 7–15 minutes.
The platform maintains explicit human control, functioning as a “co-pilot for strategy—never an autopilot.” This approach delivers board-ready recommendations, DCF valuations, 60+ financial ratios, and exportable models while preserving leadership oversight.
Percision’s three pillars—speed measured in minutes rather than weeks, depth from 27+ frameworks, and retained human authority—differentiate it from both traditional consultancies and fully automated tools.
What this looks like when the analysis is actually run
Oversight is not a review step bolted on at the end. It is whether the output tells a human where to look and what would change the answer.
The subject is TechNova Solutions, a sample company profile we use for testing rather than a customer: a $45M ARR DevOps platform, 280 employees, Series B.
Excerpt from a real Percision run · Growth & Portfolio (T3) · sample company profile
Every risk with a named owner. Bundling response from a hyperscaler: probability 5, impact 4, score 20 — mitigation, 108% NRR differentiation plus mid-market focus, owner CRO. Sales cycle extension: 4 and 5, score 20 — channel at 30% of pipeline plus a portal in Q4, owner CRO. Regulatory in verticals: 4 and 5, score 20 — legal audit pre-pilot, owner CLO. Talent for data and AI: 4 and 4, score 16 — offshore plus hires at $2M, owner CHRO. Localization: 4 and 4, score 16 — $1M cap, RFP test, owner COO.
The hypotheses a human has to sign off. ACV at least $28K in Singapore: 10 proofs of concept, pass 8 of 10, $200K over 6 months. Channel partners at 30% of pipeline: 5 MoUs, $2M committed, $100K over 4 months. Churn at 6% or better: cohort Q1, $50K over 9 months.
The decision reserved for a person, with a date. The CEO must decide by 2026-06-30 whether to approve the $9.7M ramp or defend the $40M core.
| Market | Y3 EBITDA | IRR | Payback (yrs) |
|---|---|---|---|
| Singapore | $0.7M | 18% | 4.2 |
| Australia | $0.4M | 15% | 4.5 |
| Canada | $1.2M | 22% | 3.8 |
Five risks, five named owners — CRO, CLO, CHRO, COO. The output does not decide; it assigns. That is what oversight looks like in practice: every material risk has a human whose job it is to watch it, and the analysis says which human.
The hypotheses do the same work upstream. Each is a claim the model is making, with a test, a budget and a deadline, so a human can approve or reject the assumption rather than the conclusion. Reviewing a recommendation is hard; reviewing "we assume $28K ACV in Singapore, here is the $200K test" is a decision an executive can actually take.
Read a complete Percision report — every page, no email required.